Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Facility Designs and Production Scales

Background ICH Guidance for Industry, Q7 (2016) Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients section 18.5 specifies that appropriate precautions should be taken to prevent potential viral contamination from pre-viral to post-viral removal/inactivation steps, but no direct ...

To read the full article and other articles in this issue, please register for a free account or log in.

We will not sell or give your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter

We will not sell or give your information to a third party. See our Privacy Policy